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Abstract. Taxol (paclitaxel) induces a microtubule 
hyperassembled state, and effectively blocks cells in mi- 
tosis. Here we report that Taxol also induces a stable 
late-G1 block in nontransformed REF-52 and WI-38 
mammalian fibroblast cells, but not in T antigen-trans- 
formed cells of the same parental lineage. G1 arrest is 
characterized by partially dephosphorylated pRb, and 
inactive cdk2 kinase. Nontransformed cells recover 
normally from Taxol arrest. In contrast, T antigen 
transformed cells continue inappropriately past both 
G1 and G2-M in the presence of Taxol, and undergo a 
rapid death upon release. These results demonstrate a 
microtubule sensitive step in G1 regulation of non- 
transformed fibroblast cells. Also, Taxol selectively in- 
duces death of transformed cells, possibly because they 
slip the Taxol-dependent G1 arrest, as well as G2/M ar- 
rest, which are both specific to nontransformed cells. 
M  ICROTUBULES play distinct roles at different stages 
of the cell cycle. During interphase, they estab- 
lish cell polarity, are involved in the organiza- 
tion of the cytoplasm, and play a vital role in vesicle trans- 
port.  During  mitosis,  microtubules  form  into  a  mitotic 
spindle  that  is  centrally important  both  in  chromosome 
congression to the metaphase plate and in chromatid sepa- 
ration during anaphase. 
In mitosis, the role of microtubules in regulating mitotic 
exit extends beyond their mechanical function in chromo- 
some movement. Microtubules also have an intrinsic regu- 
latory function in mitotic exit, perhaps serving as the site 
of degradation of cyclin B  and for inactivation of p34  cdc2 
kinase  (Kubiak  et  al.,  1993;  Andreassen  and  Margolis, 
1994). We have recently found that there is a strong corre- 
lation between the assembly state of microtubules and the 
metabolic ability of the cell to inactivate p34  cdc2 and induce 
mitotic exit (Andreassen and Margolis, 1994). Nocodazole 
inhibits microtubule assembly in  a  concentration-depen- 
dent manner (Hoebeke et al.,  1976; Jordan et al.,  1992), 
and concentrations of nocodazole that block microtubule 
assembly also inhibit the activation of the mitotic exit ma- 
chinery. In contrast to nocodazole, Taxol (paclitaxel) in- 
duces hyperassembly of microtubules (Schiff et al.,  1979; 
Jordan et al., 1993). BHK cells blocked with Taxol in mito- 
sis undergo inappropriate mitotic exit, either through  the 
checkpoint override activity of the protein kinase inhibi- 
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tor, 2-aminopurine, or as a result of natural "mitotic slip- 
page" (Andreassen and Margolis, 1994). 
The demonstration that microtubules have an intrinsic 
regulatory function in the control of mitotic exit has raised 
the intriguing prospect that such microtubule-dependent 
control could extend to other stages of the cell cycle. Here, 
we report that microtubules are also involved in regulating 
the transition from G1 to S phase in nontransformed fibro- 
blast ceils. We find that, in addition to its capacity to in- 
duce mitotic arrest, Taxol causes normal mammalian cells 
to arrest indefinitely late in the G1 phase of the cell cycle. 
Furthermore, we find that Taxol-dependent G1 arrest oc- 
curs only in nontransformed cells, and that SV40 large T 
antigen transformed cells of the same parental lineage do 
not arrest in G1 in response to Taxol. Since the arrest we 
observe is unique to nontransformed cells, our results sug- 
gest the presence of a microtubule sensitive step in the G1 
regulatory machinery of nontransformed cells. 
The presence of both late G1 and mitotic controls that 
are sensitive to the state of microtubule assembly suggests 
that  microtubules may be  of general  importance  to  the 
regulation  of cell  cycle progression.  We  have  observed 
that Taxol-treated transformed cells fail to arrest stably 
both in G1 and in G2/M, and exhibit inappropriate mitotic 
exit through slippage, while the parental line arrests stably 
at both points. The absence of sustained mitotic or G1 ar- 
rest in the presence of Taxol correlates with our finding 
that the drug has a remarkable ability to selectively induce 
death in transformed fibroblast cells. Thus, we find in ac- 
cord with a recent report (Wahl et al.,  1996), that trans- 
formed cells treated with Taxol rapidly and quantitatively 
die in protocols where nontransformed cells of the same 
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While Wahl et al. (1996) observed G1 arrest in nontrans- 
formed cells, they interpreted the arrest as a  late conse- 
quence of DNA damage as Taxol-treated cells passed through 
mitosis. For the first time, we demonstrate here that Taxol 
causes nontransformed cells to arrest in G1 as a primary 
event, and not as a result of previous DNA damage. 
These results show that Taxol is selectively lethal to T 
antigen-transformed  tumor cells,  possibly by subversion 
of drug-induced mitotic and G1 arrest. Taxol is a promis- 
ing  drug  in  the  treatment  of breast and  ovarian tumors 
(Rowinsky and Donehower, 1995). These results may of- 
fer an explanation of the apparent efficacy of Taxol in tu- 
mor therapy. Our results also suggest the possibility of an 
assay to screen for other drugs that might exploit the pro- 
pensity  of certain  tumor cells  to  evade  the  microtubule 
sensitive G1 and G2/M arrest points. 
Materials and Methods 
Cell Culture 
REF-52 (rat primary fibroblasts) and SV40 large T  antigen-transformed 
progeny cells (TAG) 1 (Perry et al., 1992)  were a  generous gift of G.R. 
Stark (Cleveland Clinic Foundation, Cleveland, OH). Human primary fi- 
broblasts WI-38 and SV404ransformed progeny cells (VA-13) were ob- 
tained from Amer. Type Culture Collection (Rockville, MD). REF-52 and 
WI-38 primary cell lines were used at less than 30 and 10 passages, respec- 
tively. Cell doubling times at mid-log phase for the various cell lines used 
are REF-52, 24 h; TAG, 18 h; WI-38, 40 h; and VA-13, 24 h. 
All cells were cultured as monolayers in DMEM (GIBCO BRL, Pais- 
ley,  UK)  supplemented with  10%  FBS  (Biological  Industries,  Israel). 
Cells were maintained in a humid incubator at 37°C in a 5% CO2 environ- 
ment. 
Synchronization 
Contact inhibited ceils were prepared by maintaining populations at con- 
fluency for 48 h. Cells were released from contact inhibition by trypsiniza- 
tion and replating as subconfluent cultures. Taxol at 5 Ixg/ml, nocodazole 
at 0.5 ~g/ml, or hydroxyurea at 2 mM were applied 2 h before release from 
contact inhibition. Taxol is a  trademark name (Bristol-Myers) for pacli- 
taxel. 
Taxol, nocodazole, and hydroxyurea were also applied to cycling cells at 
5 ~g/ml, 0.5 p.g/ml, and 2 mM, respectively. Taxol, nocodazole, and hy- 
droxyurea were obtained from Sigma Chem. Co (St. Louis, MO). Taxol 
and nocodazole were prepared as stock solutions in DMSO at 5 mg/ml 
and 1 mg/ml, respectively. Hydroxyurea was prepared as a 200-mM stock 
solution in DMEM containing 10% FBS. 
Immunofluorescence Microscopy 
Cells were grown on poly-lysine-coated glass coverslips. For immunolo- 
calization  of  microtubules,  cells  were  fixed  20  min  at  37°C  with  2% 
paraformaldehyde in PBS, washed with PBS, permeabilized with 0.2% 
Triton X-100 in PBS for 3 rain, and washed with PBS. Anti-l~-tubulin as- 
cites antibodies (Sigma Chemical Co., TUB 2.1) were diluted 400-fold. In- 
cubation with primary and secondary antibodies, washes, and counter- 
staining with propidium iodide were performed as previously described 
(Andreassen et al., 1991). 
For immunolocalization of PCNA, cells were fixed with 1% formalde- 
hyde at RT for 2 rain, and were then postfixed with methanol at -20°C for 
10 min, and treated with 0.5% NP-40 for 2 min (Ogata et al., 1987).  Cells 
were  washed  with  PBS,  and  then  incubated  with  primary  antibodies 
(Coulter, Miami, FL) diluted 50-fold. Cells were then washed, incubated 
with secondary antibodies, and counterstained with propidium iodide. For 
1. Abbreviations  used in this paper: 2-AP, 2-aminopurine; HU, hydroxy- 
urea; TAG, T-antigen transformed REF-52 cell; TUNEL transferase-mediated 
dUTP-biotin nick end labeling. 
all  immunofluorescence, primary antibodies were  detected  with FITC- 
conjugated goat anti-mouse IgG secondary antibodies at 2.5 p~g/ml. 
For microscopy, coverslips were mounted as previously described (An- 
dreassen et al., 1991)  and observed using an MRC-600 Laser Scanning 
confocal  apparatus  (Bio-Rad  Microscience  Division,  Herts,  England). 
Photographs were taken on TMAX-100 film with a Polaroid CI-3000 film 
recorder. 
Flow Cytometric Analysis 
Cells were collected by trypsinization, pooled with nonattached ceils, re- 
suspended in  PBS,  and  fixed by  the  addition  of methanol to  90%  at 
-20°C. After 10 min fixation, cells were pelleted, resuspended, and stored 
in PBS with 0.04% sodium azide. Cells were prepared for flow cytometry 
by washing with PBS and resuspending in 4 mM sodium citrate containing 
30 U/ml RNase A, 0.1% Triton X-100, and 50 IJ.g/ml propidium iodide and 
incubated for 10 min at 37°C. Sodium chloride was then added at 138 mM 
and samples were kept on ice until analyzed. 
Data were collected using a FACScan (Becton Dickinson &  Co., San 
Jose, CA) and results were analyzed with LYSYS II software. For each 
sample, 5,000 events were collected and aggregated cells were gated out. 
Immunoblotting 
To prepare  immunoblots, 20 Ixg of whole cell lysates were resolved on 
polyacrylamide gels. Semi-dry transfer of proteins to nitrocellulose for de- 
tection of all antigens (except pRb, which was transferred to Immobilon) 
and blocking with 5% nonfat milk in TNT buffer (25 mM Tris, pH 7.5, 150 
mM sodium chloride, and 0.05% Tween 20) was as previously described 
(Andreassen and Margolis, 1994). Blots were washed twice with TNT and 
incubated 3 h  with primary antibodies in TNT. Primary antibodies used 
were anti-human Rb (Pharmingen, San Diego, CA) and anti-p27 (Trans- 
duction Laboratories, Lexington, KY) diluted 2,000-fold; anti-p21  waF1/¢Ir'l 
(C19) and anti-cdk4 from Santa Cruz Biotechnologies (Santa Cruz, CA) 
diluted 500-fold; and anti-cdk2 antiserum (Brrnot-Bosc et al., 1995),  the 
kind gift of R. Fotedar (Inst. de Biologie Structurale, Grenoble, France), 
diluted 3,000-fold. Washes, incubation with HRP-conjugated goat anti- 
mouse and anti-rabbit IgG secondary antibodies, and revelation by en- 
hanced  chemiluminescence (Amersham Corp,  Buckinghamshire, UK) 
was as previously described (Andreassen and Margolis, 1994). 
Cdk2 Kinase Assay 
REF-52 cells at contact inhibition, or from populations released from con- 
tact inhibition into either 5 ~g/ml Taxol or 2 mM HU for 20 h were col- 
lected by trypsinization, washed with cold PBS, and cell lysates were pre- 
pared in 50 mM Tris-HCl, pH 7.4, 250 mM NaCl, 5 mM EGTA, 0.1% NP- 
40 containing 0.1 mM PMSF, 10 ~g/ml aprotinin, 10 ~g/ml leupeptin, 60 
mM [3-glycerophosphate, 50 mM NaF, and 0.5 mM sodium vanadate as 
previously described (Andreassen and Margolis, 1994). 
40 Ixg of each extract was incubated with 25 p~l of protein A-Sepharose 
4B beads for 30 min at 4°C to preclear proteins that bind nonspecifically to 
the beads. 4.0 pJ of anti-cdk2 antiserum (Brrnot-Bosc et al., 1995)  was 
added to the extract for 1 h at 4°C. Then, 50 Ixl of protein A-Sepharose 
beads was  added  for  1  h  at  4°C.  The  resulting immune complex was 
washed three times with lysis buffer and one time in kinase buffer. The pel- 
let was resuspended in 50 p3 of kinase buffer (50 mM Tris, pH 7.4, 10 mM 
MgC12, 1 mM DT/', 0.1 mg/ml BSA) containing i  p.g histone H1, 30 IxM 
ATP, and 5 ~LCi  of [3,-32p]ATP. The H1 kinase assay was carried out for 30 
min at 37°C and was terminated by the addition of sample buffer. Samples 
were then resolved by SDS-PAGE using 12% polyacrylamide gels (19:1 
ratio of acrylamide to bis-acrylamide)  (Andreassen and Margolis, 1994). 
Autoradiographs were prepared  by exposure to Hyperfilm-MP (Amer- 
sham Corp.). 
Cdk4 Kinase Assay 
REF-52 cells at contact inhibition, or from populations released from con- 
tact inhibition into either 5 p~g/ml Taxol or 2 mM HU for 20 h were col- 
lected by trypsinization and washed with 50 mM Hepes, pH 7.5, 150 mM 
NaCl, 1 mM EDTA, 2.5 mM EGTA, and 1 mM dithiothreitol. Cells were 
then lysed in the above buffer supplemented with 10%  glycerol, 0.1% 
Tween 20, 0.1 mM PMSF, 10 ~g/ml aprotinin, 10 p~g/ml leupeptin, 10 mM 
13-glycerophosphate, 1 mM NaF, and 0.1 mM sodium vanadate by sonica- 
tion two times for  10 s  according to the protocol  of Matsushime et al. 
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5 min at 12,000 g. 
40 p.g of each extract was incubated with 10 Ixl of protein G-Agarose 
beads for 60 min at 4°C to preclear proteins that bind nonspecifically to 
the beads. 10 p,l of anti-cdk4 antibody (goat polyclonal IgG C-22, Santa 
Cruz Biotechnologies) was added to the extract for 1 h at 4°C. The result- 
ing immune complex was washed three times with lysis buffer and one 
time in kinase buffer. The pellet was resuspended in 50 p,1 of kinase buffer 
(50 mM Hepes, pH 7.5, 10 mM MgCl2, 2.5 mM EGTA, 10 mM 13-glycero- 
phosphate, 1 mM NaF, 0.1  mM sodium vanadate) containing 0.5 Ixg of 
pRb substrate (carboxy terminal peptide, Santa Cruz Biotechnologies), 20 
I~M ATP and  10 ~Ci [~32p]ATP. The kinase reaction was conducted for 
30 min at 30°C. Samples were resolved by SDS-PAGE using 12% poly- 
acrylamide gels (30:0.8  ratio of acrylamide to bis-acrylamide). 
Analysis of Cell Death and Apoptosis 
Cells were grown as monolayers and treated as described in the text. At 
timepoints, cells from individual plates initially seeded at equal cell den- 
sity  were  collected  by  trypsinization  and  resuspended  in  trypan  blue 
(Sigma Chem. Co, St. Louis, MO) diluted to 0.1% in PBS for 5 min at RT. 
Viable cells, distinguished by the exclusion of trypan blue, were counted 
using a Thoma counting chamber (Germany). All data points consisted of 
three counts of at least 100 living cells. The standard deviation was <5% 
of the ordinate value for all data points. 
Apoptotic cells growing on coverslips were  detected  microscopically 
using terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick 
end  labeling  (TUNEL).  After  appropriate  drug treatment, TAG  cells 
were fixed with 1% formaldehyde in PBS for 15 rain at ambient tempera- 
ture. Cells were permeabilized 2.5 min with 0.5% Triton X-100 in PBS, 
and washed two times 5 min each with 25 mM Tris-HC1, pH 6.6, contain- 
ing 200 mM potassium cacodylate and 2.5 mM cobalt chloride. Cells were 
then incubated with the above buffer containing 0.25 mg/ml bovine serum 
albumin, 100 U/ml terminal deoxynucleotide transferase, and 10 I~M bi- 
otin 16-dUTP for 45 min at 37°C.  Cells were then washed with PBS, and 
then incubated with 60 mM trisodium citrate and 600 mM sodium chloride 
containing 0.1% Triton X-100, 5% nonfat milk and 2.5 Ixg/ml FITC-avidin 
for 1 h at 37°C.  Samples were then washed with PBS and mounted. For 
quantification of apoptosis, three counts of 200 cells each were made for 
each sample. 
Results 
Taxol Arrests REF-52 and WI-38 Cells with Both 2N 
and 4N DNA Content, but Arrests Their Transformed 
Variants with 4N Content Only 
After continuous exposure of random cycling rat embryo 
fibroblasts (REF-52) primary nontransformed cells to 5 ixM 
Taxol, flow cytometric analysis shows the presence of two 
distinct populations.  After 20 h  of treatment  with Taxol, 
the population displays two sharp peaks, representing 2N 
and 4N DNA content (Fig. 1 A). In these cells, the 2N and 
4N peaks appear stable, yielding essentially the same pop- 
ulation distribution  after 40 h  of exposure to Taxol (33% 
2N), compared to 20 h  of exposure (36%  2N) (Fig.  1 A). 
After 20 h (cell doubling time in the absence of drugs is 24 h) 
of exposure to nocodazole, REF-52 cells have almost en- 
tirely transited through the cell cycle, and are nearly all ar- 
rested in a 4N state that remains stable at 40 h  (Fig. 1 A). 
The possibility can therefore be excluded that a portion of 
the population remains 2N because it is not in the celt cy- 
cle during the time course of exposure to Taxol. 
Taxol  exposure  arrests  REF-52 cells  at  a  point  before 
the onset of S phase. If, instead, REF-52 cells are blocked 
with hydroxyurea (HU) for 15 h, and then released from 
the HU block into 5 IxM Taxol, the population is entirely 
4N after a total elapsed time of 25 h (see Fig. 3). We con- 
clude that the point of Taxol blockage is most likely in the 
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Figure 1.  Taxol  arrests  random  cycling REF-52  cells  but  not 
TAG cells  as a  2N population.  Random cycling ("untreated") 
REF-52 and TAG cells were grown to ~30%  confluency, and 
then treated with 5 IxM Taxol for either 20 or 40 h. After 20 or 40 h 
of treatment with Taxol, REF-52 cells are stably arrested as both 
2N and 4N populations. In contrast, TAG ceils do not exhibit ei- 
ther stable 2N or 4N arrest. At 20 h they are 4N, but by 40 h they 
have largely evaded mitotic arrest  and progressed through the 
next cell cycle and have 8N DNA content. In contrast to the ef- 
fect of Taxol, 1.0 tzg/ml nocodazole yields a stable 4N block in 
REF-52 cells. Data were collected by flow cytometry. 
G1 phase of the cell cycle, as it neither coincides with nor 
comes after the point of blockage with HU, which occurs 
early in S phase (Walters et al., 1976). 
In sharp contrast to the above results, REF-52 cells that 
have been  transformed  by introduction  of SV40 large  T 
antigen,  designated  TAG  cells,  exhibit  no Taxol-depen- 
dent arrest in a 2N state (Fig. 1 B). Instead, after a period 
of exposure to Taxol for 20 h, randomly cycling TAG cells 
exhibit a 4N peak. After 40 h in Taxol, a substantial frac- 
tion of the population has undergone mitotic slippage and 
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mulating as 8N cells (Fig.  1 B). 
In  summary,  nontransformed  REF-52  cells  arrest  in 
their  cell  cycle as  both  2N  and  4N  cells  in  response  to 
Taxol. While nocodazole or Taxol will arrest the cells in a 
4N state, 2N arrest arises uniquely from Taxol, and is not 
duplicated with nocodazole. Large T  antigen transforma- 
tion of REF-52 cells completely abrogates the 2N arrest 
point, and may introduce an element of mitotic slippage. 
We next addressed whether the 2N arrest in response to 
Taxol arises in another nontransformed cell line.  Random 
cycling primary human lung cells (WI-38) were exposed to 
5 txM Taxol, and after 40 h of exposure (cell doubling time 
is  40  h)  they  also  exhibited  sharp  peaks  at  2N  and  4N 
DNA content (Fig.  2 A). Again, in common with REF-52 
cells,  the point of arrest in these cells is at late G1. WI-38 
cells released from contact inhibition into HU for 20 h ar- 
rest at S phase onset. When released from HU into 5 ~M 
Taxol for an additional 20 h, they then transit from early 
S phase to mitosis, yielding a strong 4N peak (Fig. 2 A). 
In contrast,  SV40-transformed WI-38 cells,  designated 
VA-13, arrested almost exclusively as a 4N population af- 
ter 20 h of exposure to Taxol (cell doubling time is 24 h) 
(Fig. 2 B). In this case, there was no difference in the pro- 
file of the arrested population, regardless of whether they 
were exposed continuously to Taxol for 20 h, or were first 
arrested with HU for 10 h then released into Taxol for an 
additional  10 h  (Fig.  2 B). Thus, nontransformed human 
lung cells,  but  not  their  transformed  counterparts,  have 
the capacity to arrest with 2N DNA content in the pres- 
ence of Taxol. 
Release of REF-52 Cells from Contact 
Inhibition into Taxol Yields a Population Blocked with 
2N DNA Content 
The arrest of REF-52 cells in a 2N state can be enhanced 
by releasing contact inhibited cells into 5 gM Taxol. Con- 
tact  inhibition  induces  arrest  of various primary cells  in 
late G1 (Polyak et al., 1994a; Defile et al., 1995). Cells in a 
contact inhibited state were treated with Taxol for 2 h be- 
fore release, and then trypsinized and replated in the pres- 
ence of 5 gM Taxol. After 25 h in Taxol, the population, 
when analyzed by flow cytometry, was found to be almost 
entirely 2N in DNA content (Fig. 3). This state persisted 
through 35 h of continuous exposure to Taxol (Fig.  3). In 
contrast, cells  exposed first to HU for 15 h during release 
from contact inhibition, and then released from HU into 
Taxol for an additional 10 h were almost entirely 4N (Fig. 3), 
demonstrating that 35 h was sufficient time for the entire 
population to transit the cell cycle from a contact inhibited 
state to Taxol arrest at G2/M. 
Interestingly,  cells  exposed  to  0.5  ixg/ml  nocodazole 
upon  release  from  contact  inhibition  consistently  ap- 
proached  a  4N  state  later  than  released  cells  that  were 
treated with HU, and then with Taxol (Fig.  3). After 25 h 
of exposure to nocodazole, the population shown was de- 
termined to be 21% G1, 28% S phase, and 48% G2/M, in 
contrast to cells  treated for 15 h in HU, and then 10 h in 
Taxol, which were 82%  G2/M. By 35 h, 72%  of the cells 
released  from  contact  inhibition  into  nocodazole  had 
reached G2/M. We conclude that transit through the early 
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Figure 2.  Taxol arrests random cycling WI-38 cells, but not VA- 
13 cells, with 2N DNA content.  Random cycling ("untreated") 
WI-38 (A; top image) and VA-13 (B; top image) cells were grown 
to ,~30% confluency, and then treated  with 5 IxM Taxol for 20 
(VA-13) or for 40 (WI-38) h. At 40 h the WI-38 cells are 40% 2N, 
while the VA-13 cells are nearly all 4N by 20 h. WI-38 cells (A; 
bottom image), first released from contact inhibition into HU for 
20 h to induce arrest in early S phase, then released into Taxol for 
an additional 20 h, arrest as a largely 4N population. Data were 
collected by flow cytometry. 
cell cycle is also sensitive to nocodazole-dependent disas- 
sembly of microtubules, yielding a lag in cell cycle progres- 
sion as opposed to the absolute G1 block imposed by Taxol. 
The microtubule network of cells released from contact 
inhibition into various drugs was examined by immunocy- 
tochemistry, revealing that 20 h of exposure to Taxol pro- 
duced extensive bundles of cytoplasmic microtubules (Fig. 
4 A), while exposure to nocodazole totally disassembled 
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Figure  3.  REF-52  cells,  released  from  contact  inhibition  into 
Taxol, arrest predominantly with 2N DNA content. REF-52 cells 
were grown to confluency, then left as a contact inhibited popula- 
tion for 48 h before release. Cells were released from contact in- 
hibition by replating at 30%  confluency.  For  Taxol  treatment, 
cells were preincubated with 5  ~LM Taxol for 2 h  before release, 
then maintained in Taxol for the times indicated.  After 25  h  in 
Taxol, 76% of the population is 2N; after 35 h, 67% is 2N. Other 
cells were similarly treated with 0.5 ixg/ml nocodazole, or with hy- 
droxyurea (HU) for 15 h, then with Taxol for either 10 or 20 h, as 
indicated.  In  these cases,  the cell  population  progresses  to  4N 
the interphase array of microtubules over the same time 
course (data not shown). By comparison, HU-blocked cells 
showed a normal interphase array of microtubules (Fig. 4 
A). Thus, the G1 arrest induced by Taxol correlates with 
rearrangement and stabilization of the microtubule array. 
Analysis of the G1 Arrest Status of Taxol-treated 
REF-52 Cells 
Release of REF-52 cells from contact inhibition into Taxol 
yields a  uniform population of 2N  cells, permitting bio- 
chemical analysis of their arrested state. PCNA, a subunit 
of the DNA polymerase complex, is present in nuclei only 
during  S  phase  (Bravo  and  MacDonald-Bravo,  1985). 
Thus, following release of REF-52 cells from contact inhi- 
bition into HU for 20 h, their nuclei are uniformly positive 
for PCNA (Fig. 4 A), indicating that the population has 
entered early S phase by this time.  In contrast, cells re- 
leased from contact inhibition into Taxol for the same pe- 
riod of time have 2N DNA content (Fig. 3), but uniformly 
contain no intranuclear PCNA stain (Fig. 4 A). The lack of 
PCNA stain in nuclei of such cells persists indefinitely in 
the continuous presence of Taxol (data not shown). Thus, 
cells released from contact inhibition into Taxol remain 
stably arrested in late G1. This conclusion comes from the 
lack of PCNA stain in the nuclei of arrested cells, and from 
evidence that the point of Taxol arrest precedes the HU 
block point. 
We have analyzed the Taxol-arrested cell population for 
the presence of distinctive late G1 markers, p21C1PI/wAF1 
and p27  Kip1 are specific inhibitors of the cdk kinases re- 
quired for the G1/S phase transition (Harper et al.,  1993; 
Polyak et al., 1994b; Toyoshima and Hunter, 1994). p27  Kip1 
is upregulated in quiescent cells and is abruptly degraded 
at the G1-S transition (Nourse et al., 1994; Pagano et al., 
1995).  Western blot analysis demonstrates that p27  Kip1 is 
prominent in contact inhibited REF-52 cells, but is at min- 
imal levels in cells blocked at S phase with HU (Fig. 4 B). 
REF-52 cells released from contact inhibition into Taxol 
contain p27  KiN levels comparable to those of contact in- 
hibited  cells,  p21CIP1/wAF1  is present in  contact inhibited 
REF-52 cells and remains present at diminished levels in 
Taxol-treated cells. This result is in sharp contrast to Wahl 
et al. (1996), who found induction of p21CIP1/wAF1  in cells 
treated with Taxol following synchronization at S phase, 
and interpreted the increase as due to a DNA damage re- 
sponse. Our results show that Taxol-dependent G1 arrest 
is  not characteristic of that following DNA  damage and 
that Taxol arrest does not appear to require p21 cIP1/wAF1 
induction. 
pRb, a protein involved in regulation of the G1-S transi- 
tion, undergoes inactivation by CDK-dependent phospho- 
rylation at the time of transition past the G1  restriction 
point (Buchkovich et al., 1989; Chen et al., 1989; DeCaprio 
et al.,  1989).  Contact inhibited  cells contain underphos- 
phorylated pRb, while a slower migrating phosphorylated 
form is evident in HU-blocked cells (Fig. 4 B). In contrast, 
in cells released from contact inhibition into Taxol, pRB 
DNA  content.  Data  were  collected  by  flow  cytometry.  In  all 
cases,  numbers  indicate  hours  of  drug  treatment  after  release 
from contact inhibition. 
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leased  from  contact  inhibi- 
tion into Taxol  are  arrested 
in late G1. (A) PCNA is ex- 
cluded from nuclei of Taxol- 
arrested  REF-52  cells 
(above,  left). REF-52  cells 
were  released  from  contact 
inhibition  into  either  5  t~M 
Taxol or 2 mM hydroxyurea 
(HU). After 25 h of release, 
cells were fixed and prepared 
for  immunofluorescence 
analysis.  PCNA serves as an 
intranuclear S phase marker. 
HU-blocked  cells  have 
PCNA  in  their  nuclei, 
whereas  Taxol-blocked cells 
do  not.  Anti-tubulin  anti- 
body reveals a characteristic 
interphase  array of microtu- 
bule (MTs) bundles in Taxol- 
treated  cells  (below, left), 
compared to the normal mi- 
crotubule  array  present  in 
HU-blocked  cells  (below, 
right). Bar, 20 I~m. (B) Taxol 
arrested  2N  REF-52  cells 
have  markers  characteristic 
of late G1. Contact-inhibited 
cells, or cells released from contact inhibition for 25 h into either Taxol or hydroxyurea (HU) were harvested. Then, to determine ex- 
pression levels of various cell cycle proteins, samples were subjected to SDS-PAGE, and then exposed to the appropriate antibodies in 
Western blotting procedures. The kinase activities  of cdk2 and cdk4 were determined following immuneprecipitation of the enzymes, 
using histone H1 or a pRb peptide as substrates, respectively.  Autoradiographs of 32p incorporation are shown. 
maintains  a  stable  state  with  approximately  half  of the 
pRb population phosphorylated. The partial phosphoryla- 
tion status of pRb in cells released from contact inhibition 
into Taxol has been repeatedly observed in independently 
prepared extracts. 
We  have  also  analyzed  the  activity  of both  cdk2  and 
cdk4 protein kinases.  Cdk4 is normally active during mid- 
to-late G1 (Matsushime  et al., 1994; Sherr, 1994), whereas 
cdk2 is activated at the point of commitment to S phase, 
and  is  required  for  S  phase  entry  (Fang  and  Newport, 
1991; Pagano et al., 1993; Tsai et al., 1993). Both enzymes 
are present  in cells at constant levels under all treatment 
conditions except for and increase  in cdk2 in HU  (Fig.  4 
B). Cdk4 shows activity in contact inhibited  cells and re- 
mains approximately as active in Taxol-arrested cells (Fig. 
4 B). The kinase activity of cdk4 is, however, diminished in 
HU-treated  cells.  Our  analysis  of  immune-precipitated 
cdk2  kinase  activity  shows  that  it  is  inactive  in  REF-52 
cells during contact inhibition, but is active in extracts pre- 
pared  from cells  blocked in S  phase with  HU  (Fig. 4  B). 
Cells  released  from contact inhibition  into Taxol contain 
inactive  cdk2 kinase  (Fig.  4  B), consistent  with  all  other 
markers demonstrating an indefinite G1 arrest in the pres- 
ence of Taxol. 
Correlation between Failure of G1 Arrest in Taxol and 
Drug Toxicity in Transformed Cells 
There  is  a  dramatic  difference between  transformed  and 
nontransformed cells of the same parental lineage with re- 
spect  to  induction  of  cell  death  following  exposure  to 
Taxol. REF-52 cells arrest in the presence of Taxol and re- 
sume  normal proliferation  upon release.  In striking  con- 
trast, TAG cells given the same drug regimen die follow- 
ing release. 
TAG cells  die within  6  d  of release  following different 
times of exposure to Taxol (Fig. 5 A). After an exposure of 
as little as 10 h (cell doubling time is 16 h), the majority of 
random cycling TAG cells ultimately die, although there is 
a  brief period  during  which a  small  amount of prolifera- 
tion occurs. After 20 or 40 h  exposure to Taxol, cell death 
commences immediately and is complete by 6 d (Fig. 5 A). 
When REF-52 cells are treated  identically,  they arrest in 
the cell cycle, then recommence proliferating upon release 
from the drug, ultimately  reaching confluency (Fig. 5 B). 
The capacity to resume proliferation is independent of the 
time of drug treatment,  between 20 and 40 h, and also in- 
dependent  of whether  the cells were randomly cycling or 
released  from  contact  inhibition  before  drug  exposure 
(data not shown). 
The period of the cell cycle in which TAG cells are ex- 
posed  to Taxol is  important  in  their  capacity to survive. 
After exposure  to Taxol for 10 h, randomly cycling cells 
gave a brief proliferative response, and then proceeded to 
die (Fig. 5, A  and C). In contrast, if the cells are first col- 
lected in early S phase by a 10-h HU block following con- 
tact inhibition, then released into Taxol for 10 h, they pro- 
ceed to mitosis  by the time Taxol is removed.  Such cells 
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upon release (Fig. 5 C). If however ceils are released from 
HU block into Taxol for 20 h, a period of time sufficient to 
allow cells to slip from mitotic arrest into the next cell cycle, 
the cells ultimately die after release from Taxol (Fig. 5 C). 
The contrast in survival demonstrates that the period of le- 
thality in response to Taxol lies between late mitosis and 
entry into S phase. 
The relative survival of cells is evident visually in phase 
contrast  images  of  random  fields of cells.  After  release 
from  20  h  of Taxol  treatment,  nontransformed  REF-52 
cells  recommence  proliferation, while  transformed  cells 
rapidly die. The  difference in cell density in  the  popula- 
tions after 48 h of release from Taxol is striking (Fig. 5 D). 
Figure 5.  Relative survival of 
REF 52  and TAG cells fol- 
lowing  Taxol  arrest.  (A) 
Randomly cycling TAG cells 
were  treated  with  5  I~M 
Taxol for 10, 20,  or 40 h, as 
indicated, then  released. At 
the indicated time points, cell 
counts were taken. (B) Ran- 
domly cycling REF  52  cells 
were  treated  with  5  txM 
Taxol for 20 or 40 h, as indi- 
cated, then  released. At the 
indicated  time  points,  cell 
counts were taken. The pla- 
teau at later times indicates 
approach to confluency. (C) 
Randomly cycling TAG ceils 
were  treated  either  with  5 
v,M Taxol for 10  h,  or with 
hydroxyurea (HU)  for 10 h, 
then with 5 I~M Taxol for ei- 
ther 10 or 20 h, as indicated, 
and then released. At the in- 
dicated  time  points,  cell 
counts were taken. (D) Phase 
contrast  images  of  random 
fields of REF 52  and  TAG 
cells taken at time 0  and at 
96  h  after release from 20 h 
of  treatment  with  5  ~M 
Taxol.  All  pictures  were 
taken at the same magnifica- 
tion.  (E)  Flow  cytometric 
analysis of DNA content  of 
REF  52  cells,  comparing  a 
randomly cycling population 
with cells treated with Taxol 
for 20  h,  and  then released. 
The sample was collected at 
contact  inhibition, 8  d  after 
release from Taxol. Bar: (D) 
60 Ixm. 
REF-52 cells were analyzed by flow cytometry 8 d  after 
release from 20  h  treatment  with Taxol, after reaching a 
state of contact inhibition. These cells have euploid DNA 
content  indistinguishable from  that  of REF-52 cells that 
were  never Taxol treated  (Fig. 5  E),  demonstrating  that 
REF-52 cells proliferate with normal ploidy. 
Flow cytometric analysis of the  DNA  content  demon- 
strates that the progression of TAG  cells toward death is 
accompanied by a  transient  population of cells with  less 
than 2N ploidy (Fig. 6 A), characteristic of apoptotic cells 
(Hotz et al., 1994), Extensive death is apparent after treat- 
ment with Taxol for either 10 or 40 h, despite the fact that 
cells treated with Taxol for 10 h  had not apparently pro- 
gressed past G2/M before release. 
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treatment is apoptotic in nature. (A) Flow 
cytometric analysis of TAG cell death fol- 
lowing release from Taxol treatment was 
performed. TAG cells were treated with 5 
izM  Taxol  for  10  or  40  h  as  indicated. 
Samples were taken for flow cytometry at 
the end of the Taxol treatment, or after 2 
or 4 d  of release, as indicated. (B) Micro- 
scopic TUNEL  assay of untreated  TAG 
cells, or of TAG cells treated with 5  IxM 
Taxol for 20 h, or of TAG cells 24 h after 
release from 20-h Taxol treatment. Back- 
ground  levels are  shown  to  indicate the 
presence  of non-apoptotic cells. In  con- 
trast to this weak background stain, apop- 
totic cells yield an intense positive signal 
(bottom image). (  C) Quantification of the 
extent of apoptosis, as determined by mi- 
croscopic  TUNEL  assay.  At  the  time 
points  indicated,  representing  time  fol- 
lowing  release  from  20  h  exposure  to 
Taxol,  TAG  cells  were  fixed  and  sub- 
jected to the TUNEL assay. The percent 
of apoptotic cells relative to total cells at 
each  time  is  shown  (hatched bars). For 
reference, the percent of cells still present 
relative to  those  at  the  time  of release 
from Taxol is also shown (solid bars). Bar: 
(B) 20 ~m. 
To  confirm that  cell death  in  response  to Taxol treat- 
ment is apoptotic, we performed a terminal deoxynucleoti- 
dyl transferase-mediated dUTP-biotin  nick  end  labeling 
(TUNEL)  assay, which is indicative of an apoptotic state 
(Gavrieli et al., 1992; Hotz et al., 1994).  There is no posi- 
tive signal by the TUNEL assay in either control cells or in 
ceils treated with Taxol for 20 h. In contrast, after 24 h re- 
lease from the drug the assay yields bright nuclear signals 
in apoptotic cells (Fig. 6 B, bottom image). The percentage 
of apoptotic cells, as scored by the TUNEL assay, at vary- 
ing  times  after  release  from  20  h  Taxol  treatment,  are 
shown in Fig. 6  C. For comparison, the number of surviv- 
ing cells relative to the time of release from Taxol is also 
shown. In accord with data from flow cytometry (Fig. 6 A), 
the relative extent of apoptosis increases with time follow- 
ing  release.  These  data  are  in  accord  with  reports  that 
Taxol induced death is apoptotic in nature  (Bhalla et al., 
1993; Donaldson et al., 1994). 
Discussion 
We have demonstrated that Taxol imposes a  durable late 
G1  block  to  cell  cycle  progression  in  nontransformed 
REF-52 and WI-38 cells. We have also shown  that SV40 
large T  antigen transformation of these cells abolishes the 
Taxol-dependent G1 block point. Finally, we have demon- 
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in transformed and nontransformed cells. 
Role of  Microtubules in Regulating 
Cell Cycle Progression 
It  is  clear  from  our  evidence  that  microtubules  are  in- 
volved in G1 control. But while nontransformed REF-52 
cells arrest in G1 in response to Taxol, T  antigen-trans- 
formed cells do not. From this difference, we can conclude 
that the G1 arrest point observed in the presence of Taxol 
is not metabolically necessary to the cell, but it rather ap- 
pears to result from a microtubule-dependent step in G1 
that  is  absent  in  transformed  cells.  Both  the  regulatory 
pathways that induce progression through G1 and the G1 
checkpoint controls that restrict progression from G1 into 
S phase can be altered in transformed cells (Donehower et 
al., 1992; Jacks et al., 1992; Hinds et al., 1994; Mansour et 
al., 1994). Thus, it is possible that either of these pathways 
may function in  a  microtubule-dependent  fashion that is 
specific to nontransformed cells. 
In the first case, it may be that a critical element of G1 
control is sequestered on microtubules, and that the acti- 
vation of this element requires its release. The release and 
activation of this element can occur either in  a  dynamic 
microtubule system, or can be triggered in the absence of 
microtubules, but would not occur when microtubules are 
completely stabilized  by Taxol.  In this  case,  only tumor 
cells which lack the G1 control would advance to S phase. 
Alternatively,  by  inducing  hyperassembly of microtu- 
bules,  Taxol might impose a  checkpoint  control  in  non- 
transformed  cells.  Checkpoint  controls,  which  normally 
function to assure the integrity of the genome, arrest the 
cell cycle at a  discrete point until  all prerequisite events 
have been completed (Hartwell and Weinert,  1989).  For 
example, cell cycle arrest normally follows DNA damage 
in G1, but this checkpoint control pathway is often ineffective 
in transformed cells (Kastan et al., 1991; Kuerbitz et al., 1992). 
Previous studies have demonstrated that disassembly of 
microtubules by colchicine and other microtubule assembly 
inhibitors had effects on cell cycle progression into S phase 
(McClain  and  Edelman,  1980;  Otto et al.,  1981;  Crossin 
and Carney, 1981), but previous results were variable and 
did not reveal a quantitative arrest in G1 by inhibitors of 
microtubule dynamics (for review see Otto, 1987).  By us- 
ing flow cytometry and biochemical assays of the compo- 
nents involved in G1 regulation, we have for the first time 
determined the presence of a stable microtubule-sensitive 
step  late  in  G1.  Also,  we  demonstrate  that  transformed 
cells and their nontransformed counterparts differ in their 
requirements  for  dynamic  microtubules  during  progres- 
sion through  G1. Until now the effect of Taxol on inter- 
phase progression has not been studied systematically. In 
the most relevant study to date, colchicine was shown to 
enhance entry into S phase under serum starvation condi- 
tions, while Taxol had an inhibitory effect on colchicine- 
dependent  progression  (Crossin  and  Carney,  1981).  In 
light of these previous observations, it is of interest to note 
that we find nocodazole, which blocks microtubule assem- 
bly  in  a  manner  similar  to  colchicine  (Hoebeke  et  al., 
1976), noticeably delays advancement from contact inhibi- 
tion to S phase (Fig. 3). 
The  results  we  have reported  here  may be compared 
with  our  previous  observations  concerning  microtubule 
control of mitotic exit (Andreassen  and Margolis,  1994). 
In that study we found that the microtubule assembly state 
determined the capacity of a cell in mitotic arrest to exit 
mitosis,  either  through  natural  "mitotic  slippage"  or 
through the effect of the protein kinase inhibitor,  2-ami- 
nopurine (2-AP). Both Taxol and nocodazole yielded ef- 
fective mitotic arrest, but 2-AP was able to induce  rapid 
exit from this blocked state under certain circumstances. 
2-AP promoted a  rapid exit from Taxol-arrested mitosis, 
while  high  nocodazole  concentrations  prevented  check- 
point override and created a stable mitotic arrest. We ob- 
served a  similar variance in the capacity of Taxol or no- 
codazole-blocked  cells  to  spontaneously  exit  mitosis 
through mitotic slippage (Andreassen and Margolis, 1994). 
Our results with mitotic cells and those presented here 
demonstrate that there are at least two points in the cell 
cycle where the microtubule assembly state can determine 
cell cycle progression. However, the effects of Taxol and 
nocodazole on mitotic exit contrast with their effects on 
G1 progression. In mitosis, nocodazole can create a stable 
block to advancement whereas Taxol cannot; while in G1, 
Taxol  creates  a  stable  block  to  cell  cycle  advancement 
where nocodazole does not. The differences in response to 
the  microtubule inhibitors  indicate  that  the  mechanisms 
underlying microtubule effects on mitotic progression and 
on G1 progression must be different. 
The Nature of the Microtubule-dependent G  I 
Control Point 
The two nontransformed cell lines that we have examined, 
REF-52 and WI-38, arrest stably in late G1 when exposed 
to Taxol. Contact inhibition  is believed to impose a  late 
G1 arrest on mammalian cells (Polyak et al., 1994a; Deffie 
et al., 1995). We have demonstrated that the drug imposed 
G1 arrest point comes after the point of arrest with contact 
inhibition.  Thus,  contact  inhibited  cells,  released  into 
Taxol,  exhibit  a  durable  and  effective  G1  arrest  in  the 
presence of the drug. 
Late G1 markers present in REF-52 cells at the time of 
contact  inhibition  are  retained  after  release  into  Taxol. 
Cdk2 protein kinase activity is required to induce the on- 
set of S  phase  (Fang  and  Newport,  1991;  Pagano  et  al., 
1993; Tsai et al., 1993).  Cdk2 activity is negligible both at 
contact inhibition and in cells arrested with Taxol follow- 
ing contact inhibition.  Thus, it appears that activation of 
cdk2 kinase is inhibited by the presence of Taxol. In con- 
trast, cdk4, which is activated in mid-to-late G1, before ac- 
tivation  of cdk2  (Matsushime  et  al.,  1994;  Sherr,  1994), 
shows activity that is equivalent in both contact-inhibited 
and in G1 Taxol-arrested cells. 
p27  Kipl, a cyclin-dependent kinase inhibitor (Polyak et al., 
1994a,b; Toyoshima and Hunter, 1994) that is specifically 
degraded  in  a  ubiquitin-dependent  pathway  during  late 
G1 (Pagano et al., 1995),  declines in abundance as the cell 
enters S phase (Nourse et al.,  1994;  Halevy et al.,  1995). 
We have found that p27  Kipl levels are equivalent in con- 
tact-inhibited and in Taxol-arrested cells. Since expression 
of p27  Kipj induces  G1  arrest  (Polyak  et  al.,  1994b;  To- 
yoshima  and  Hunter,  1994),  the  continued  presence  of 
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bition of cdk2 activity, p21C1P1AvAF1, which like p27  Kipl, is a 
specific inhibitor of cdk2, is present at diminished levels in 
Taxol-arrested  G1  cells  relative  to  its  level  in  contact- 
inhibited cells. In response to DNA damage, p53 induces 
high expression levels of p21 clP1/wAF1 in G1 cells (E1-Deiry 
et al.,  1994), and p21 clvvwgFt  then suppresses cell cycle 
progression to S phase (Harper et al.,  1993; Deng et al., 
1995).  Our results thus demonstrate that Taxol does not 
arrest REF-52 cells in G1 through induction of p21CIPI/wAFI. 
These results are in sharp contrast to the results of Wahl et 
al. (1996), who report an induction of p21  cIPl~vml  and G1 
arrest, subsequent to cell transit through mitosis following 
a brief treatment with Taxol. Thus, the primary G1 arrest 
that we observe in response to Taxol results from a molec- 
ular mechanism distinct from that reported previously. 
Another criterion that indicates that Taxol arrests non- 
transformed  cells  in  G1,  before  the  onset  of  S  phase, 
comes from immunolocalization of PCNA. PCNA, a com- 
ponent  of the  DNA  replication complex  (Bravo  et  al., 
1987)  that  localizes to  the  nucleus  throughout  S  phase 
(Bravo and MacDonald-Bravo, 1985), is present in the nu- 
clei of REF-52 cells released from contact inhibition into 
HU, but is excluded from the nuclei of both contact-inhib- 
ited cells and cells released from contact inhibition into 
Taxol. 
pRb  negatively regulates  progression from G1  into  S 
phase.  It  is  unphosphorylated  in  contact-inhibited  cells 
and through most of G1, but becomes phosphorylated as 
the cell progresses to S  phase  (Buchkovich et al.,  1989; 
Chen  et al.,  1989;  DeCaprio et  al.,  1989).  Lack of pRb 
phosphorylation arrests the cell in late G1, and phosphory- 
lation relieves this inhibition  (for review see  Hinds  and 
Weinberg, 1994).  In cells released from contact inhibition 
into Taxol, pRb becomes only partially phosphorylated. 
This change  indicates that  the  cell has  measurably pro- 
gressed from the contact inhibited state to a distinct block 
point in late G1. Association with pRb inhibits the tran- 
scription factor E2F (Hiebert et al., 1992; Weintraub et al., 
1992),  thereby repressing transcription of several key ele- 
ments required for progression to S phase. E2F binds the 
underphosphorylated  form  of  pRb  (Chellappan  et  al., 
1991),  and  cdk-dependent  phosphorylation  of pRb  dis- 
rupts the complex and releases the repression of transcrip- 
tional  activation  by  E2F  (Dynlacht  et  al.,  1994).  Both 
cdk4/cdk6, associated with cyclins of the D class (D1, D2, 
and D3), and cdk2-cyclin E, have been implicated in the 
phosphorylation of pRb (for review see Hinds and Wein- 
berg, 1994). Since cdk2 is inactive in Taxol-arrested REF- 
52 cells, partial phosphorylation of pRb must be mediated 
by  either  the  cdk4  activity  observed,  or  through  cdk6. 
However, the  mechanism  underlying the  change  in  the 
pRb phosphorylation state is currently unknown. 
Taxol-dependent arrest in G1  does not occur in TAG 
cells,  which  were  transformed by introduction of SV40 
large T  antigen (Perry et al.,  1992).  The transforming ca- 
pacity of T antigen has been linked to its distinct effects on 
G1  control  mechanisms.  T  antigen  disrupts  several  key 
negative regulators of progression from G1 into S phase. 
SV40 large T  antigen and other viral oncoproteins, bind 
exclusively  to  the  underphosphorylated  form  of  pRb 
(Ludlow et al., 1989), thereby sequestering active pRb and 
inhibiting  its  growth  suppressive  function  (Hinds  et  al., 
1992).  T  antigen also binds to p53  (Lane and Crawford, 
1979;  Linzer and  Levine, 1979)  and p107  (Dyson et al., 
1989), two other proteins that negatively regulate entry into 
S phase. Interaction of the NH2-terminal region of T antigen 
with p53 suppresses p53-mediated growth arrest (Quartin 
et al., 1994), and has been directly linked to the capacity of 
T antigen to immortalize primary cells (Zhu et al., 1991). 
It is more likely that Taxol-treated cells arrest in G1 due 
to a microtubule-dependent checkpoint control, than that 
they fail to progress from contact inhibition due to an indi- 
rect effect of the loss of microtubule organization on the 
function of the signal transduction machinery. If this were 
true, one would expect a  similar effect with nocodazole, 
since  nocodazole disrupts  the  microtubule  cytoskeleton 
more profoundly than Taxol. However, we have shown 
that nocodazole does not induce a stable G1 block to cell 
cycle progression. 
One can assume that some components of the machin- 
ery necessary for G1 progression in nontransformed cells 
must associate with microtubules. The results we have pre- 
sented here should make a search for microtubule-associ- 
ated elements involved in G1 control worthwhile, and we 
are  currently pursuing  this  direction of inquiry. We are 
also  currently working  to  determine  the  mechanism  by 
which Taxol interferes with cdk2 activation and pRb phos- 
phorylation during G1. 
Implications for Tumor Therapy 
Different microtubule inhibitors vary in their ability to se- 
lectively destroy tumor cells in a clinical setting. While the 
chemotherapeutic effect of microtubule inhibitors would 
seem in some way linked to the most evident effect of the 
drugs, mitotic arrest, there is no direct evidence in support 
of this assumption. Both Taxol and nocodazole impose mi- 
totic arrest on mammalian cells. Taxol has shown promise 
in chemotherapy, particularly in the treatment of ovarian 
and  breast  tumors  (Rowinsky  and  Donehower,  1995), 
while nocodazole has not. The difference in chemothera- 
peutic efficacy may lie in two more subtle effects in the cell 
cycle. We have shown that Taxol can induce a rapid mi- 
totic slippage, whereas higher concentrations of nocoda- 
zole create a stable mitotic block (Andreassen and Mar- 
golis, 1994).  Furthermore, as we have shown here, Taxol 
produces a stable G1 block that selectively occurs in non- 
transformed fibroblast cells, while nocodazole does not in- 
duce G1 arrest. We are currently working to determine if 
similar effects occur in nonfibroblast cell lines. 
We have shown elsewhere that Taxol enhances mitotic 
slippage  (Andreassen  and  Margolis,  1994),  and  have 
shown here that transformed TAG cells undergo mitotic 
slippage with Taxol, while nontransformed REF-52 cells 
do not (Fig.  1). We have observed similar differences in 
mitotic slippage between WI-38 and VA-13 cells (our un- 
published observations). It is therefore possible that mi- 
totic slippage in Taxol may produce selective lethality in 
tumor ceils, and that failure to arrest in G1 ultimately ex- 
poses  the  entire  transformed cell population  to  mitotic 
slippage. 
The lethal event may also occur on passage from G1 to S 
in Taxol, since our results have indicated that cell death is 
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S  phase.  Other recent studies have suggested  that Taxol 
may have a lethal effect early in the cell cycle (Donaldson 
et al., 1994; Hennequin et al., 1995). The early cell cycle ef- 
fect is even more striking for a Taxol-related drug, taxo- 
tere, and it has been suggested that lethality may be related 
to inhibition of centrosome duplication during interphase 
(Hennequin et al., 1995). 
We show that Taxol is not lethal to TAG ceils if they are 
exposed to the drug during the period of the cell cycle be- 
tween early S phase and exit from mitosis. These conclu- 
sions were  drawn from  an experiment  where  TAG  cells 
were either exposed to Taxol alone or were released from 
HU into Taxol. Cells released from HU and then exposed 
to Taxol during the period of the cell cycle between early 
S phase and exit from mitosis experienced no lethal effect, 
whereas  exposure of a randomly cycling, and mostly G1, 
population  to  Taxol  for  an  equivalent  period  of  time 
yielded substantial lethality. 
In addition to raising some  very  interesting biological 
questions concerning the capacity of the microtubule as- 
sembly state to determine G1 progression, our results may 
suggest a unique target for tumor chemotherapy. It is pos- 
sible that a screen of drugs that interfere with microtubule 
dynamics  for  a  subset  differentially  capable  of arresting 
nontransformed  cells  in  G1  will  yield  a  unique  class  of 
compounds with unusual selectivity for tumor cells. 
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